MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Gracell Biotechnologies Inc. (NASDAQ: GRCL)
Organization & Developments: Gracell Biotechnologies
Parents
Gracell Biotechnologies Inc. (NASDAQ: GRCL)
Children
2024: AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)
Gracell focused on developing CAR-T cell therapies by leveraging its technology platforms FasTCAR and TruUCAR to deliver younger, less exhausted T cells for autologous cell therapies with enhanced activities and next-day manufacturing
Jumps
Finance & Acquisition: Gracell Biotechnologies
Key People: Gracell Biotechnologies